1
|
Huby T, Le Guillou E, Burin des Roziers C, Pacot L, Briand-Suleau A, Chansavang A, Toussaint A, Duchossoy V, Vaucouleur N, Benoit V, Lodé L, Molac C, North MO, Grotto S, Tsatsaris V, Jouinot A, Cochand-Priollet B, Paepegaey AC, Nectoux J, Groussin L, Pasmant E. Noninvasive Prenatal Diagnosis of a Paternally Inherited MEN1 Pathogenic Splicing Variant. J Clin Endocrinol Metab 2022; 107:e1367-e1373. [PMID: 34897474 DOI: 10.1210/clinem/dgab894] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Indexed: 11/19/2022]
Abstract
CONTEXT Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1. The uncertainty of pathogenicity of MEN1 variants complexifies the selection of the patients likely to benefit from specific care. OBJECTIVE MEN1-mutated patients should be offered tailored tumor screening and genetic counseling. We present a patient with hyperparathyroidism for whom genetic analysis identified a variant of uncertain significance in the MEN1 gene (NM_130799.2): c.654G > T p.(Arg218=). Additional functional genetic tests were performed to classify the variant as pathogenic and allowed prenatal testing. DESIGN Targeted next generation sequencing identified a synonymous variant in the MEN1 gene in a 26-year-old male with symptomatic primary hyperparathyroidism. In silico and in vitro genetic tests were performed to assess variant pathogenicity. RESULTS Genetic testing of the proband's unaffected parents showed the variant occurred de novo. Transcript study showed a splicing defect leading to an in-frame deletion. The classification of the MEN1 variant as pathogenic confirmed the diagnosis of MEN1 and recommended an adapted medical care and follow-up. Pathogenic classification also allowed to propose a genetic counseling to the proband and his wife. Noninvasive prenatal diagnosis was performed with a personalized medicine-based protocol by detection of the paternally inherited variant in maternal plasmatic cell free DNA, using digital PCR. CONCLUSION We showed that functional genetic analysis can help to assess the pathogenicity of a MEN1 variant with crucial consequences for medical care and genetic counseling decisions.
Collapse
Affiliation(s)
- Thomas Huby
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
| | - Edouard Le Guillou
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
| | - Cyril Burin des Roziers
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
- Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, CARPEM, Paris, France
| | - Laurence Pacot
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
- Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, CARPEM, Paris, France
| | - Audrey Briand-Suleau
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
- Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, CARPEM, Paris, France
| | - Albain Chansavang
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
- Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, CARPEM, Paris, France
| | - Aurélie Toussaint
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
| | - Véronique Duchossoy
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
| | - Nicolas Vaucouleur
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
| | - Virginie Benoit
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
| | - Laurence Lodé
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
| | - Clémence Molac
- Maternité Port-Royal, FHU PREMA, AP-HP, Hôpital Cochin, AP-HP.Centre-Université de Paris, Université de Paris, Paris, France
| | - Marie-Odile North
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
| | - Sarah Grotto
- Maternité Port-Royal, FHU PREMA, AP-HP, Hôpital Cochin, AP-HP.Centre-Université de Paris, Université de Paris, Paris, France
| | - Vassilis Tsatsaris
- Maternité Port-Royal, FHU PREMA, AP-HP, Hôpital Cochin, AP-HP.Centre-Université de Paris, Université de Paris, Paris, France
| | - Anne Jouinot
- Department of Endocrinology, Hôpital Cochin, AP-HP.Centre-Université de Paris, Université de Paris, Paris, France
| | - Béatrix Cochand-Priollet
- Department of Pathology, Cochin Hospital, AP-HP.Centre-Université de Paris, Université de Paris, Paris, France
| | | | - Juliette Nectoux
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
| | - Lionel Groussin
- Department of Endocrinology, Hôpital Cochin, AP-HP.Centre-Université de Paris, Université de Paris, Paris, France
| | - Eric Pasmant
- Service de Génétique et Biologie Moléculaires, Hôpital Cochin, DMU BioPhyGen, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université de Paris, Paris, France
- Institut Cochin, Inserm U1016, CNRS UMR8104, Université de Paris, CARPEM, Paris, France
| |
Collapse
|
2
|
Lewitzki V, Wegener S, Toussaint A, Flentje M, Pollmann S. PO-1635 Dosimetric characterization of patient-specific three-dimensional tissue-equivalent bolus. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)08086-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
3
|
Hamy-Petit AS, Toussaint A, Sautter C, Coussy F, Donnadieu A, Rouzier R, Saule C, Frank S, Bensen A, Grynberg M, Scarabin-Carre V, Santulli P, Balezeau T, Guerin J, Reyrat E, Jamain C, Hours A, Lecourt A, Reyal F. Abstract P6-16-02: Fertility preservation in young breast cancer patients: Real life data on 1390 patients treated in the Institut Curie. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p6-16-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Adverse effects of chemotherapy on fertility are a critical concern for young breast cancer (BC) patients. Fertility preservation (FP) is currently offered to BC patients, though literature data concerning reproductive outcomes are scarce. Also, very few data are available on whether these procedures are associated with delay to treatment, or whether they impact oncologic outcomes. The objective of our study is to evaluate: (i) efficacy of FP procedures in terms of stored material and pregnancy rates, (ii) safety regarding time from BC diagnosis to chemotherapy, and oncologic outcomes in a large real-life cohort of BC patients.
Methods: We retrospectively analyzed medical charts of all consecutive patients aged between 18 and 43 diagnosed with invasive BC between 01/01/2011 and 30/09/2017 and treated with chemotherapy at Institut Curie (Paris and Saint Cloud). Baseline factors (antral follicle count (AFC), AMH), details on fertility preservation procedures, and results (number of frozen oocytes and embryos) were retrieved in 3 academic hospitals (Jean Verdier, Antoine Béclère and Cochin). All medical charts were reviewed in March 2018 to assess time from diagnosis to surgery / chemotherapy, pregnancy outcomes, recurrence and survival. We compared time from first consultation to start of chemotherapy (time diagnosis-to-CT) in case of neoadjuvant chemotherapy (NAC between patients who had or who did not have PF.
Results: On 1.390 patients identified, 622 had NAC, 768 had adjuvant CT. Median age at diagnosis was 38.8 y.o. 136 were BRCA mutated.
- 264 patients (19%) underwent a FP procedure: In Vitro Maturation (IVM) (58%, n=154); ovarian stimulation protocol (STIM) (31%, n=82); others (10%, n=28). The mean number of oocytes preserved was 5 [0-36] and was not different between IMV and STIM.
- Delays from diagnosis to CT were not different in patients who had FP than those who did not, neither in patients with NAC (no FP: 24.1 days VS FP: 22.8, p=0.24) nor in patients with adjuvant CT (no FP: 70.6 days VS FP : 66.8, p=0.11).
- 39 patients had at least one pregnancy: 28 spontaneous, 6 without information, and 5 from oocyte/embryo donation. The pregnancy rate was higher in patients in FP group (n=16 ; 6%) than in no FP group (n=23 ; 2%). 3 reused material : 2 without pregnancy and one had a miscarriage.
- About oncologic outcomes, 90 patients underwent relapse (6,4%), and this rate was not significantly different in the 2 groups (n=12, 4,5% VS n=78, 6.9%).
- Patients with BRCA mutation (BRCAm) had lower AMH (2.9 VS 4.1 ng/mL ; p = 0,03) and antral follicle count (17.6 VS 24 ; p = 0.01). However, there was no difference on the stored material, and pregnancy rate was higher than in patients with no mutation or unkwnown status (7.6 VS 2.6% ; p = 0,01).
Conclusion: Pregnancy rate was higher in patients with FP, however majority of pregnancies was spontaneous, and no live birth was observed after material reuse. FP procedures were not associated with delay to treatment. Though bias cannot be excluded, preliminary data do not show an adverse impact of FP on oncologic outcome. Further follow-up is needed.
Citation Format: Hamy-Petit A-S, Toussaint A, Sautter C, Coussy F, Donnadieu A, Rouzier R, Saule C, Frank S, Bensen A, Grynberg M, Scarabin-Carre V, Santulli P, Balezeau T, Guerin J, Reyrat E, Jamain C, Hours A, Lecourt A, Reyal F. Fertility preservation in young breast cancer patients: Real life data on 1390 patients treated in the Institut Curie [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P6-16-02.
Collapse
Affiliation(s)
- A-S Hamy-Petit
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - A Toussaint
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - C Sautter
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - F Coussy
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - A Donnadieu
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - R Rouzier
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - C Saule
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - S Frank
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - A Bensen
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - M Grynberg
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - V Scarabin-Carre
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - P Santulli
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - T Balezeau
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - J Guerin
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - E Reyrat
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - C Jamain
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - A Hours
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - A Lecourt
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| | - F Reyal
- Curie Institute, Paris, France; Antoine Beclere Hospital, Clamart, France; Port Royal Hospital, Paris, France; Unicancer Federation, Paris, France
| |
Collapse
|
4
|
Bau S, Payet R, Toussaint A, Witschger O, Todea AM, Monz C, Asbach C. Combining NSAM and CPC concentrations to determine airborne nanoparticle count median diameter: Application to various laboratory and workplace aerosols. J Occup Environ Hyg 2018; 15:492-501. [PMID: 29580178 DOI: 10.1080/15459624.2018.1449953] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Because nanomaterials have been increasingly developed and used in many technology and industry sectors over the last 20 years, an increasing number of workers is likely to be exposed to airborne nanoparticles. In addition, the question of the nanomaterial characteristics that should be assessed in epidemiological studies remains open. Thus, assessing occupational exposure to airborne nanoparticles will not only rely on mass concentration and chemical composition. Rather, key parameters, such as particle size, have to be included in measurement strategies. We previously proposed a methodology to estimate the Count Median Diameter (CMD) of an aerosol based on the simultaneous size-integrated measurement of two particle concentrations, lung-deposited surface area, and number, thanks to field-portable, commercially available aerosol instruments (Nanoparticle Surface Area Monitor/Condensation Particle Counter combination). In addition to previous work, this study investigates the case of various polydisperse metal oxides, organic oil, and salt particles with CMDs ranging from 16-410 nm. Once corrected, the CMDs derived from the NSAM/CPC agree within ±20% with regard to the reference electrical mobility equivalent diameter, regardless of aerosol composition, morphology, or geometric standard deviation (GSD). Furthermore, the field-applicability of the method was tested through 6 sets of experimental data stemming from workplace measurement campaigns where different materials were produced and handled (TiO2, SiO2, Ag, Multi-Walled Carbon Nanotubes-MWCNT), covering a range of CMDs between 40 and 190 nm. All situations considered, the approach based on the combination of a NSAM and a CPC leads to a satisfying estimation of particle CMD, within ±20% compared to reference CMD.
Collapse
Affiliation(s)
- S Bau
- a Institut National de Recherche et de Sécurité, Laboratoire de Métrologie des Aérosols , Vandoeuvre , France
| | - R Payet
- a Institut National de Recherche et de Sécurité, Laboratoire de Métrologie des Aérosols , Vandoeuvre , France
| | - A Toussaint
- a Institut National de Recherche et de Sécurité, Laboratoire de Métrologie des Aérosols , Vandoeuvre , France
| | - O Witschger
- a Institut National de Recherche et de Sécurité, Laboratoire de Métrologie des Aérosols , Vandoeuvre , France
| | - A M Todea
- b Institut für Energie und Umwelttechnik e. V. (IUTA) , Duisburg , Germany
| | - C Monz
- c Institut für Gefahrstoffforschung (IGF) , Bochum , Germany
| | - C Asbach
- b Institut für Energie und Umwelttechnik e. V. (IUTA) , Duisburg , Germany
| |
Collapse
|
5
|
Tabibzadeh N, Cheddani L, Daudon M, Haymann JP, Toussaint A, Silve C, Letavernier E. The Case | Epistasis and urolithiasis. Kidney Int 2017; 92:523-524. [PMID: 28709611 DOI: 10.1016/j.kint.2017.01.026] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2016] [Revised: 01/19/2017] [Accepted: 01/31/2017] [Indexed: 11/24/2022]
Affiliation(s)
- Nathalie Tabibzadeh
- Sorbonne Université-UPMC Paris 06, UMR S 1155, Paris, France; INSERM, UMR S 1155, Paris, France; Explorations fonctionnelles multidisciplinaires, AP-HP, Hôpital Tenon, Paris, France
| | - Lynda Cheddani
- Explorations fonctionnelles multidisciplinaires, AP-HP, Hôpital Tenon, Paris, France
| | - Michel Daudon
- Sorbonne Université-UPMC Paris 06, UMR S 1155, Paris, France; INSERM, UMR S 1155, Paris, France; Explorations fonctionnelles multidisciplinaires, AP-HP, Hôpital Tenon, Paris, France
| | - Jean-Philippe Haymann
- Sorbonne Université-UPMC Paris 06, UMR S 1155, Paris, France; INSERM, UMR S 1155, Paris, France; Explorations fonctionnelles multidisciplinaires, AP-HP, Hôpital Tenon, Paris, France
| | - Aurélie Toussaint
- Service de Biochimie et Génétique Moléculaire, AP-HP, Hôpital Cochin, Paris, France
| | - Caroline Silve
- Service de Biochimie et Génétique Moléculaire, AP-HP, Hôpital Cochin, Paris, France; INSERM U1169, Université Paris Sud, Hôpital Bicêtre, Le Kremlin Bicêtre, France; Centre de Référence des Maladies Rares du Métabolisme du Phosphore et du Calcium and Filière de Santé Maladies Rares OSCAR, AP-HP, Paris, France
| | - Emmanuel Letavernier
- Sorbonne Université-UPMC Paris 06, UMR S 1155, Paris, France; INSERM, UMR S 1155, Paris, France; Explorations fonctionnelles multidisciplinaires, AP-HP, Hôpital Tenon, Paris, France.
| |
Collapse
|
6
|
Ben Ameur S, Silve C, Chabchoub I, Damak F, Kamoun F, Toussaint A, Kmiha S, Sfaihi L, Maaloul I, Kamoun T, Aloulou H, Hachicha M. Clinical and Genetic Characterization of Tunisian Children with Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets. Horm Res Paediatr 2017; 87:23-29. [PMID: 28013309 DOI: 10.1159/000452886] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/28/2016] [Accepted: 10/26/2016] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Hereditary vitamin D-resistant rickets (HVDRR) is an autosomal recessive disorder characterized by the early onset of rickets and is caused by mutations in the vitamin D receptor (VDR) gene. Some HVDRR patients also have alopecia. PATIENTS AND METHODS We retrospectively studied the clinical features, laboratory findings, genetic defects, as well as responses to treatment in a series of children with HVDRR. RESULTS Eight patients from 7 families met the inclusion criteria. Alopecia was noted in 7 patients. Two different homozygous mutations in the VDR gene were identified in 6 patients: the p.K45E mutation located in the DNA-binding domain (5 patients with alopecia) and a novel p.T415R mutation located in the ligand-binding domain. A p.E143del CYP24A1 mutation, in the gene encoding the 25-hydroxyvitamin D3-24-hydroxylase, was identified in 2 brothers carrying the VDR gene mutation p.K45E. Six patients were treated with intermittent intravenous calcium treatment via the peripheral route with a clear improvement in 5 cases. CONCLUSION To the best of our knowledge, this is the first major series reporting on HVDRR in Tunisia. The same mutation (p.K45E) was found in 5 apparently unrelated affected individuals. We have also extended the mutation spectrum by studying 1 novel VDR mutation.
Collapse
|
7
|
Palmer A, Hayman O, Toussaint A, Sauer O. EP-1985: Proposal to improve commissioning of HDR brachytherapy with results from the first 2 SagiNova units. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)33236-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
8
|
Toussaint A, Charpin N, Brosse S, Villéger S. Global functional diversity of freshwater fish is concentrated in the Neotropics while functional vulnerability is widespread. Sci Rep 2016; 6:22125. [PMID: 26980070 PMCID: PMC4793233 DOI: 10.1038/srep22125] [Citation(s) in RCA: 71] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2015] [Accepted: 02/05/2016] [Indexed: 11/21/2022] Open
Abstract
Worldwide biodiversity assessments have mainly focused on species richness but little is known about the diversity of species roles, i.e. functional diversity, while this is a key facet to understanding the consequences of global changes on the ecosystem services to human societies. Here, we report the world pattern of functional diversity of freshwater fish using a database encompassing morphological characteristics of more than 9,000 species. The Neotropical realm hosts more than 75% of global functional diversity while other realms each host less than 25%. This discrepancy is mediated by high functional uniqueness in some diversified Neotropical fish orders. Surprisingly, functional diversity patterns were weakly related to functional vulnerability. In the Neotropics the loss of threatened species will cause a limited loss of functional diversity (<10%) whereas in the Nearctic and Palearctic realms, decline of the functional diversity will reach 43% and 33%, respectively, conferring a high functional vulnerability to these realms. Conservation of the Neotropical fish diversity is a key target to maintain world fish functional diversity, but this should not hide the pressing need to conserve the vulnerable fish faunas of the rest of the world, in which functional diversity is to a large extent supported by threatened species.
Collapse
Affiliation(s)
- A Toussaint
- CNRS, UPS, ENFA, UMR 5174 EDB (Laboratoire Évolution et Diversité Biologique), Université Paul Sabatier, 118 route de Narbonne, F-31062 Toulouse, France
| | - N Charpin
- CNRS, UPS, ENFA, UMR 5174 EDB (Laboratoire Évolution et Diversité Biologique), Université Paul Sabatier, 118 route de Narbonne, F-31062 Toulouse, France
| | - S Brosse
- CNRS, UPS, ENFA, UMR 5174 EDB (Laboratoire Évolution et Diversité Biologique), Université Paul Sabatier, 118 route de Narbonne, F-31062 Toulouse, France
| | - S Villéger
- Laboratoire Biodiversité Marine et ses Usages (MARBEC), UMR 9190 CNRS-UM-IFREMER-IRD, Université de Montpellier, CC 093, F-34095 Montpellier Cedex 5, France
| |
Collapse
|
9
|
Degos B, Toussaint A, Lesage S, Brice A, Vidailhet M, Beldjord C, Catala M. PINK1 and FLNA mutations association: A role for atypical parkinsonism? Parkinsonism Relat Disord 2016; 26:78-80. [PMID: 26969111 DOI: 10.1016/j.parkreldis.2016.02.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/28/2015] [Revised: 02/20/2016] [Accepted: 02/29/2016] [Indexed: 10/22/2022]
Affiliation(s)
- Bertrand Degos
- Département des Maladies du Système Nerveux, Centre Inter-Régional de Coordination de la Maladie de Parkinson, Hôpital Pitié-Salpêtrière, APHP, Paris, 75013, France.
| | - Aurélie Toussaint
- Biochimie et Génétique Moléculaire, Hôpital Cochin, AP-HP, Université Paris Descartes, Paris, France
| | - Suzanne Lesage
- Sorbonne Universités, UPMC Univ Paris 6 UMR S 1127, Inserm U 1127, CNRS UMR 722, Institut du Cerveau et de la Moelle épinière, Paris, France
| | - Alexis Brice
- Sorbonne Universités, UPMC Univ Paris 6 UMR S 1127, Inserm U 1127, CNRS UMR 722, Institut du Cerveau et de la Moelle épinière, Paris, France; Institut Hospitalo-Universitaire (IHU), Hôpital Pitié-Salpêtrière, APHP, Paris, 75013, France
| | - Marie Vidailhet
- Département des Maladies du Système Nerveux, Centre Inter-Régional de Coordination de la Maladie de Parkinson, Hôpital Pitié-Salpêtrière, APHP, Paris, 75013, France; Sorbonne Universités, UPMC Univ Paris 6 UMR S 1127, Inserm U 1127, CNRS UMR 722, Institut du Cerveau et de la Moelle épinière, Paris, France; Institut Hospitalo-Universitaire (IHU), Hôpital Pitié-Salpêtrière, APHP, Paris, 75013, France
| | - Chérif Beldjord
- Biochimie et Génétique Moléculaire, Hôpital Cochin, AP-HP, Université Paris Descartes, Paris, France
| | - Martin Catala
- Département des Maladies du Système Nerveux, Centre Inter-Régional de Coordination de la Maladie de Parkinson, Hôpital Pitié-Salpêtrière, APHP, Paris, 75013, France; Université Pierre et Marie Curie-Paris 6, Laboratoire de Biologie du Développement, UMR 7622, Paris, 75005, France; Centre National de la Recherche Scientifique, Laboratoire de Biologie du Développement, UMR 7622 Paris, 75005, France
| |
Collapse
|
10
|
Echevarria L, Benistan K, Toussaint A, Dubourg O, Hagege A, Eladari D, Jabbour F, Beldjord C, De Mazancourt P, Germain D. X-chromosome inactivation in female patients with Fabry disease. Clin Genet 2015; 89:44-54. [DOI: 10.1111/cge.12613] [Citation(s) in RCA: 226] [Impact Index Per Article: 25.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2014] [Revised: 05/03/2015] [Accepted: 05/12/2015] [Indexed: 12/11/2022]
Affiliation(s)
- L. Echevarria
- Division of Medical Genetics; University of Versailles; Montigny France
- Assistance Publique - Hôpitaux de Paris (AP-HP); Referral Center for Fabry Disease and Inherited Disorders of Connective Tissue; Garches France
| | - K. Benistan
- Assistance Publique - Hôpitaux de Paris (AP-HP); Referral Center for Fabry Disease and Inherited Disorders of Connective Tissue; Garches France
| | - A. Toussaint
- Laboratory of Biochemistry and Molecular Biology; University Paris V Descartes; Paris France
| | - O. Dubourg
- Department of Cardiology; University of Versailles; Boulogne France
| | - A.A. Hagege
- Department of Cardiology, HEGP (APHP); Paris France
| | - D. Eladari
- Department of Physiology, HEGP (APHP); University Paris V Descartes; Paris France
| | - F. Jabbour
- Assistance Publique - Hôpitaux de Paris (AP-HP); Referral Center for Fabry Disease and Inherited Disorders of Connective Tissue; Garches France
| | - C. Beldjord
- Laboratory of Biochemistry and Molecular Biology; University Paris V Descartes; Paris France
| | - P. De Mazancourt
- UFR des sciences de la santé; University of Versailles; Montigny France
| | - D.P. Germain
- Division of Medical Genetics; University of Versailles; Montigny France
- Assistance Publique - Hôpitaux de Paris (AP-HP); Referral Center for Fabry Disease and Inherited Disorders of Connective Tissue; Garches France
- UFR des sciences de la santé; University of Versailles; Montigny France
| |
Collapse
|
11
|
Fallet-Bianco C, Laquerrière A, Poirier K, Razavi F, Guimiot F, Dias P, Loeuillet L, Lascelles K, Beldjord C, Carion N, Toussaint A, Revencu N, Addor MC, Lhermitte B, Gonzales M, Martinovich J, Bessieres B, Marcy-Bonnière M, Jossic F, Marcorelles P, Loget P, Chelly J, Bahi-Buisson N. Mutations in tubulin genes are frequent causes of various foetal malformations of cortical development including microlissencephaly. Acta Neuropathol Commun 2014; 2:69. [PMID: 25059107 PMCID: PMC4222268 DOI: 10.1186/2051-5960-2-69] [Citation(s) in RCA: 84] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2014] [Accepted: 06/04/2014] [Indexed: 01/18/2023] Open
Abstract
Complex cortical malformations associated with mutations in tubulin genes are commonly referred to as “Tubulinopathies”. To further characterize the mutation frequency and phenotypes associated with tubulin mutations, we studied a cohort of 60 foetal cases. Twenty-six tubulin mutations were identified, of which TUBA1A mutations were the most prevalent (19 cases), followed by TUBB2B (6 cases) and TUBB3 (one case). Three subtypes clearly emerged. The most frequent (n = 13) was microlissencephaly with corpus callosum agenesis, severely hypoplastic brainstem and cerebellum. The cortical plate was either absent (6/13), with a 2–3 layered pattern (5/13) or less frequently thickened (2/13), often associated with neuroglial overmigration (4/13). All cases had voluminous germinal zones and ganglionic eminences. The second subtype was lissencephaly (n = 7), either classical (4/7) or associated with cerebellar hypoplasia (3/7) with corpus callosum agenesis (6/7). All foetuses with lissencephaly and cerebellar hypoplasia carried distinct TUBA1A mutations, while those with classical lissencephaly harbored recurrent mutations in TUBA1A (3 cases) or TUBB2B (1 case). The third group was polymicrogyria-like cortical dysplasia (n = 6), consisting of asymmetric multifocal or generalized polymicrogyria with inconstant corpus callosum agenesis (4/6) and hypoplastic brainstem and cerebellum (3/6). Polymicrogyria was either unlayered or 4-layered with neuronal heterotopias (5/6) and occasional focal neuroglial overmigration (2/6). Three had TUBA1A mutations and 3 TUBB2B mutations. Foetal TUBA1A tubulinopathies most often consist in microlissencephaly or classical lissencephaly with corpus callosum agenesis, but polymicrogyria may also occur. Conversely, TUBB2B mutations are responsible for either polymicrogyria (4/6) or microlissencephaly (2/6).
Collapse
|
12
|
Toussaint A, Visée P, Detournay D. [Management of acute iliac thrombosis in a pregnancy at term: case discussion and review of literature]. Rev Med Brux 2013; 34:411-415. [PMID: 24303655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Venous thromboembolic disease during pregnancy is an important cause of obstetric morbidity and mortality. Suggestive clinical signs lead systematically physicians to evocate this diagnosis. Unfortunately, the incidence of events remains low, reducing the ability to perform well-designed research and to give adequate recommendations. The discovery in term pregnancy of an iliofemoral venous thrombosis raises the question of obstetrical care, mainly considering potentially embolic risk. Through a case report and based on a thinking about the few medical publications in this field, we suggest that the placing of temporary inferior vena cava filter in presence of an extensive deep venous thrombosis at term pregnancy could be debatable.
Collapse
Affiliation(s)
- A Toussaint
- Département de Chirurgie vasculaire, Grand Hôpital de Charleroi.
| | | | | |
Collapse
|
13
|
Mercier S, Toutain A, Toussaint A, Raynaud M, de Barace C, Marcorelles P, Pasquier L, Blayau M, Pénisson-Besnier I, Romero N, Espil C, Parent P, Journel H, Lazaro L, Andoni Urtizberea J, Moerman A, Faivre L, Eymard B, Maincent K, Gherardi R, Chaigne D, Ben Yaou R, Leturcq F, Chelly J, Desguerre I. Erratum: Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age. Eur J Hum Genet 2013. [DOI: 10.1038/ejhg.2013.74] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
14
|
Dufour E, Toussaint A, Liu N, Fischler M, Nourry G, Vercoutère M. Ultrasound-guided perineural circumferential median nerve block in carpal tunnel syndrome. Anaesthesia 2013; 68:434-6. [PMID: 23488853 DOI: 10.1111/anae.12212] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
15
|
Vasson A, Leroux C, Orhant L, Boimard M, Toussaint A, Leroy C, Commere V, Ghiotti T, Deburgrave N, Saillour Y, Atlan I, Fouveaut C, Beldjord C, Valleix S, Leturcq F, Dodé C, Bienvenu T, Chelly J, Cossée M. Custom oligonucleotide array-based CGH: a reliable diagnostic tool for detection of exonic copy-number changes in multiple targeted genes. Eur J Hum Genet 2013; 21:977-87. [PMID: 23340513 PMCID: PMC3746255 DOI: 10.1038/ejhg.2012.279] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2012] [Revised: 10/31/2012] [Accepted: 11/13/2012] [Indexed: 11/09/2022] Open
Abstract
The frequency of disease-related large rearrangements (referred to as copy-number mutations, CNMs) varies among genes, and search for these mutations has an important place in diagnostic strategies. In recent years, CGH method using custom-designed high-density oligonucleotide-based arrays allowed the development of a powerful tool for detection of alterations at the level of exons and made it possible to provide flexibility through the possibility of modeling chips. The aim of our study was to test custom-designed oligonucleotide CGH array in a diagnostic laboratory setting that analyses several genes involved in various genetic diseases, and to compare it with conventional strategies. To this end, we designed a 12-plex CGH array (135k; 135 000 probes/subarray) (Roche Nimblegen) with exonic and intronic oligonucleotide probes covering 26 genes routinely analyzed in the laboratory. We tested control samples with known CNMs and patients for whom genetic causes underlying their disorders were unknown. The contribution of this technique is undeniable. Indeed, it appeared reproducible, reliable and sensitive enough to detect heterozygous single-exon deletions or duplications, complex rearrangements and somatic mosaicism. In addition, it improves reliability of CNM detection and allows determination of boundaries precisely enough to direct targeted sequencing of breakpoints. All of these points, associated with the possibility of a simultaneous analysis of several genes and scalability 'homemade' make it a valuable tool as a new diagnostic approach of CNMs.
Collapse
Affiliation(s)
- Aurélie Vasson
- Assistance Publique-Hôpitaux de Paris, Laboratoire de Biochimie et Génétique Moléculaire, Hôpital Cochin, APHP, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Mercier S, Toutain A, Toussaint A, Raynaud M, de Barace C, Marcorelles P, Pasquier L, Blayau M, Espil C, Parent P, Journel H, Lazaro L, Andoni Urtizberea J, Moerman A, Faivre L, Eymard B, Maincent K, Gherardi R, Chaigne D, Ben Yaou R, Leturcq F, Chelly J, Desguerre I. Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age. Eur J Hum Genet 2013; 21:855-63. [PMID: 23299919 DOI: 10.1038/ejhg.2012.269] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2012] [Revised: 08/30/2012] [Accepted: 09/25/2012] [Indexed: 01/30/2023] Open
Abstract
The molecular basis underlying the clinical variability in symptomatic Duchenne muscular dystrophy (DMD) carriers are still to be precised. We report 26 cases of early symptomatic DMD carriers followed in the French neuromuscular network. Clinical presentation, muscular histological analysis and type of gene mutation, as well as X-chromosome inactivation (XCI) patterns using DNA extracted from peripheral blood or muscle are detailed. The initial symptoms were significant weakness (88%) or exercise intolerance (27%). Clinical severity varied from a Duchenne-like progression to a very mild Becker-like phenotype. Cardiac dysfunction was present in 19% of the cases. Cognitive impairment was worthy of notice, as 27% of the carriers are concerned. The muscular analysis was always contributive, revealing muscular dystrophy (83%), mosaic in immunostaining (81%) and dystrophin abnormalities in western blot analysis (84%). In all, 73% had exonic deletions or duplications and 27% had point mutations. XCI pattern was biased in 62% of the cases. In conclusion, we report the largest series of manifesting DMD carriers at pediatric age and show that exercise intolerance and cognitive impairment may reveal symptomatic DMD carriers. The complete histological and immunohistological study of the muscle is the key of the diagnosis leading to the dystrophin gene analysis. Our study shows also that cognitive impairment in symptomatic DMD carriers is associated with mutations in the distal part of the DMD gene. XCI study does not fully explain the mechanisms as well as the wide spectrum of clinical phenotype, though a clear correlation between the severity of the phenotype and inactivation bias was observed.
Collapse
|
17
|
Toussaint A, Schulz K, Petermann F, Lipsius M. Lese-Rechtschreib-Störung. Monatsschr Kinderheilkd 2012. [DOI: 10.1007/s00112-012-2762-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
18
|
Terren M, Saverys S, De Haveskercke PJ, Toussaint A, Baudoin P, Locht F, Mergeai G. Study of agronomic constraints to the dissemination of the cultivation of Jatropha curcas L. in Senegal. Commun Agric Appl Biol Sci 2012; 77:245-249. [PMID: 22558790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Affiliation(s)
- M Terren
- Durabilis Foundation, Kortrijksesteenweg 930, BE-9000 Ghent, Belgium
| | | | | | | | | | | | | |
Collapse
|
19
|
Abid G, Muhovski Y, Jacquemin J, Silue S, Toussaint A, Baudoin J. A spatiotemporal analysis of sucrose synthase during seed development in wild-type and EMS mutant embryos of common bean (Phaseolus vulgaris L.) using in situ hybridization. N Biotechnol 2009. [DOI: 10.1016/j.nbt.2009.06.965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
20
|
Köhler V, Mazet C, Toussaint A, Kulicke K, Häussinger D, Neuburger M, Schaffner S, Kaiser S, Pfaltz A. Chiral Boron-Bridged Bisoxazoline (Borabox) Ligands: Structures and Reactivities of Pd and Cu Complexes. Chemistry 2008; 14:8530-9. [DOI: 10.1002/chem.200800822] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
21
|
Toussaint A, Pfaltz A. Asymmetric Henry Reactions Catalyzed by Metal Complexes of Chiral Boron-Bridged Bisoxazoline (borabox) Ligands. European J Org Chem 2008. [DOI: 10.1002/ejoc.200800570] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
22
|
Toussaint A, Nicot A, Dondaine N, Kretz C, Poirson C, Zanoteli E, Wallgren-Pettersson C, Echaniz-Laguna A, Bomme Ousager L, Krause A, Jern C, Merlini L, Oliveira A, Biancalana V, Mandel J, Laporte J. C.P.4.10 Mutation spectrum of the large GTPase dynamin 2 in autosomal centronuclear myopathy. Neuromuscul Disord 2007. [DOI: 10.1016/j.nmd.2007.06.400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
23
|
Mazet C, Köhler V, Roseblade S, Toussaint A, Pfaltz A. Synthesis of Boron-Bridged Anionic C2-Symmetric Bisoxazolines and Their Application in Asymmetric Catalysis. Chimia (Aarau) 2006. [DOI: 10.2533/000942906777674958] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
24
|
Toussaint A, de Timary P. [Drawing the alcoholic out of his isolation]. J Pharm Belg 2006; 61:37-44. [PMID: 16669346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/09/2023]
Abstract
Alcohol is by far the most frequent addiction across industrial countries. Associated with unrest, rejection and other negative counter-attitudes, alcohol dependence often confines the patient to isolation. The objective of this article is to describe potential obstacles to access to health care, the strategies enabling this access and finally different programs and therapeutic modalities of a long-term treatment. This article focuses on these issues in term of level of intervention.
Collapse
Affiliation(s)
- A Toussaint
- Secteur de psychiatrie de liaison, Service de psychiatrie adulte de l'UCL
| | | |
Collapse
|
25
|
Felim A, Toussaint A, Phillips CR, Leca D, Vagstad A, Fensterbank L, Lacôte E, Malacria M. Improved Method for the Iodine(III)-Mediated Preparation of Aryl Sulfonimidates. Org Lett 2005; 8:337-9. [PMID: 16408909 DOI: 10.1021/ol052790t] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
[reaction: see text] One-pot hypervalent iodine-mediated oxidations of arylsulfinamides to arylsulfonimidates is reported. Contrary to the case of alkylsulfinamides, use of iodosobenzene was not satisfactory. The reaction worked best with diacetoxyiodosobenzene (DIB) and a mild base (MgO). The influence of substituents on the iodine(III) reagent arene has been examined.
Collapse
Affiliation(s)
- Anne Felim
- Université Pierre et Marie Curie, Institut de Chimie Moléculaire (FR 2769), Laboratoire de Chimie Organique (UMR CNRS 7611), Paris, France
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Beyer TF, Tackenberg B, Alfke B, Iwinska-Zelder J, Shiratori K, Toussaint A, Sommer N, Bien S. MRT T2 Läsionslast und korrespondierender Liquor-IgG-Index bei Patienten mit Neuritis Nervi optici und Multipler Sklerose. Eine retrospektive Pilotstudie. ROFO-FORTSCHR RONTG 2005. [DOI: 10.1055/s-2005-868324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
27
|
Leca D, Toussaint A, Mareau C, Fensterbank L, Lacôte E, Malacria M. Efficient Copper-Mediated Reactions of Nitrenes Derived from Sulfonimidamides. Org Lett 2004; 6:3573-5. [PMID: 15387551 DOI: 10.1021/ol0485520] [Citation(s) in RCA: 58] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
[reaction: see text] Sulfonimidamides lead efficiently to nitrenes and have been converted to sulfimides, sulfoximines, and aziridines in good yields, through a copper-mediated multicomponent reaction. The stereogenic sulfur atom and the trivalent nitrogen atom present in the molecules open the way to asymmetric synthesis, whose first results are presented.
Collapse
Affiliation(s)
- Dominique Leca
- Université Pierre et Marie Curie, Laboratoire de Chimie Organique, UMR CNRS 7611, 4 place Jussieu, C. 229, 75005 Paris, France
| | | | | | | | | | | |
Collapse
|
28
|
Shiratori K, Spernal J, Toussaint A, Gurschi M, Hemmeter U, Bien S. Diffusionsgewichtete Magnet-Resonanz-Tomographie nach elektrokonvulsiver Therapie (EKT). ROFO-FORTSCHR RONTG 2004. [DOI: 10.1055/s-2004-827481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
29
|
Shiratori K, Mrowka M, Toussaint A, Spalke G, Bien S. Extreme, unilateral widening of Virchow-Robin spaces: case report. Neuroradiology 2002; 44:990-2. [PMID: 12483444 DOI: 10.1007/s00234-002-0840-9] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2002] [Accepted: 05/23/2002] [Indexed: 11/25/2022]
Abstract
We report a case of extreme, largely unilateral dilatation of Virchow-Robin spaces. Fluid-attenuated inversion-recovery images revealed high-signal foci adjacent to the dilated spaces, possibly due to chronic ischaemia.
Collapse
Affiliation(s)
- K Shiratori
- Department of Neuroradiology, Philipps-University Marburg, Rudolf-Bultmann-Strasse 8, 35039 Marburg, Germany.
| | | | | | | | | |
Collapse
|
30
|
|
31
|
Abstract
The small regulatory RNA SsrA has both tRNA and mRNA activities. It charges alanine and interacts with stalled ribosomes, allowing for translation to resume on the SsrA mRNA moiety. Hence, unfinished peptides carry a short amino acid tag, which serves as a signal for degradation by energy-dependent proteases. In SsrA-defective Escherichia coli strains, thermoinducible mutants of the transposable bacteriophage Mu (Mucts) are no longer induced at high temperature. Here we show that truncated forms of the key regulator of Mu lysogeny, the repressor Repc, accumulate in the absence of SsrA. These forms resemble C-terminally truncated dominant Mu repressor mutants previously isolated from Mucts, which are no longer thermoinducible and bind operator DNA with a high affinity even at high temperature. Using various ssrA alleles, we demonstrate the importance of SsrA charging on the ribosome for controlling Mu prophage repression. Our results thus substantiate the previous observation that trans-translation is not the only function of the SsrA. The alternative function of SsrA appears to influence the stability of Mu lysogens by controlling the translation of the C-terminal domain of the repressor protein, which modulates the affinity of the protein for DNA and its susceptibility to proteolytic degradation.
Collapse
Affiliation(s)
- C Ranquet
- Laboratoire Plasticité et Expression des Génomes Microbiens, Centre National de la Recherche Scientifique FRE2383, Université J. Fourier, BP 53, F-38041 Grenoble Cedex 9, France.
| | | | | |
Collapse
|
32
|
Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, Gennari C, Reginster JY. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA 2001; 285:1482-8. [PMID: 11255425 DOI: 10.1001/jama.285.11.1482] [Citation(s) in RCA: 118] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
CONTEXT Data on the efficacy and safety of ipriflavone for prevention of postmenopausal bone loss are conflicting. OBJECTIVES To investigate the effect of oral ipriflavone on prevention of postmenopausal bone loss and to assess the safety profile of long-term treatment with ipriflavone in postmenopausal osteoporotic women. DESIGN AND SETTING Prospective, randomized, double-blind, placebo-controlled, 4-year study conducted in 4 centers in Belgium, Denmark, and Italy from August 1994 to July 1998. PARTICIPANTS Four hundred seventy-four postmenopausal white women, aged 45 to 75 years, with bone mineral densities (BMDs) of less than 0.86 g/cm(2). INTERVENTIONS Patients were randomly assigned to receive ipriflavone, 200 mg 3 times per day (n = 234), or placebo (n = 240); all received 500 mg/d of calcium. MAIN OUTCOME MEASURES Efficacy measures included spine, hip, and forearm BMD and biochemical markers of bone resorption (urinary hydroxyproline corrected for creatinine and urinary CrossLaps [Osteometer Biotech, Herlev, Denmark] corrected for creatinine), assessed every 6 months. Laboratory safety measures and adverse events were recorded every 3 months. RESULTS Based on intent-to-treat analysis, after 36 months of treatment, the annual percentage change from baseline in BMD of the lumbar spine for ipriflavone vs placebo (0.1% [95% confidence interval (CI), -7.9% to 8.1%] vs 0.8% [95% CI, -9.1% to 10.7%]; P =.14), or in any of the other sites measured, did not differ significantly between groups. The response in biochemical markers was also similar between groups (eg, for hydroxyproline corrected for creatinine, 20.13 mg/g [95% CI, 18.85-21.41 mg/g] vs 20.67 mg/g [95% CI, 19.41-21.92 mg/g]; P =.96); urinary CrossLaps corrected for creatinine, 268 mg/mol (95% CI, 249-288 mg/mol) vs 268 mg/mol (95% CI, 254-282 mg/mol); P =.81. The number of women with new vertebral fracture was identical or nearly so in the 2 groups at all time points. Lymphocyte concentrations decreased significantly (500/microL (0.5 x 10(9)/L]) in women treated with ipriflavone. Thirty-one women (13.2%) in the ipriflavone group developed subclinical lymphocytopenia, of whom 29 developed it during ipriflavone treatment. Of these, 15 (52%) of 29 had recovered spontaneously by 1 year and 22 (81%) of 29 by 2 years. CONCLUSIONS Our data indicate that ipriflavone does not prevent bone loss or affect biochemical markers of bone metabolism. Additionally, ipriflavone induces lymphocytopenia in a significant number of women.
Collapse
Affiliation(s)
- P Alexandersen
- Center for Clinical and Basic Research, Ballerup Byvej 222, 2750 Ballerup, Denmark.
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Springael D, Ryngaert A, Merlin C, Toussaint A, Mergeay M. Occurrence of Tn4371-related mobile elements and sequences in (chloro)biphenyl-degrading bacteria. Appl Environ Microbiol 2001; 67:42-50. [PMID: 11133426 PMCID: PMC92512 DOI: 10.1128/aem.67.1.42-50.2001] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Tn4371, a 55-kb transposable element involved in the degradation and biphenyl or 4-chlorobiphenyl identified in Ralstonia eutropha A5, displays a modular structure including a phage-like integrase gene (int), a Pseudomonas-like (chloro)biphenyl catabolic gene cluster (bph), and RP4- and Ti-plasmid-like transfer genes (trb) (C. Merlin, D. Springael, and A. Toussaint, Plasmid 41:40-54, 1999). Southern blot hybridization was used to examine the presence of different regions of Tn4371 in a collection of (chloro)biphenyl-degrading bacteria originating from different habitats and belonging to different bacterial genera. Tn4371-related sequences were never detected on endogenous plasmids. Although the gene probes containing only bph sequences hybridized to genomic DNA from most strains tested, a limited selection of strains, all beta-proteobacteria, displayed hybridization patterns similar to the Tn4371 bph cluster. Homology between Tn4371 and DNA of two of those strains, originating from the same area as strain A5, extended outside the catabolic genes and covered the putative transfer region of Tn4371. On the other hand, none of the (chloro)biphenyl degraders hybridized with the outer left part of Tn4371 containing the int gene. The bph catabolic determinant of the two strains displaying homology to the Tn4371 transfer genes and a third strain isolated from the A5 area could be mobilized to a R. eutropha recipient, after insertion into an endogenous or introduced IncP1 plasmid. The mobilized DNA of those strains included all Tn4371 homologous sequences previously identified in their genome. Our observations show that the bph genes present on Tn4371 are highly conserved between different (chloro)biphenyl-degrading hosts, isolated globally but belonging mainly to the beta-proteobacteria. On the other hand, Tn4371-related mobile elements carrying bph genes are apparently only found in isolates from the environment that provided the Tn4371-bearing isolate A5.
Collapse
Affiliation(s)
- D Springael
- Environmental Technology, Flemish Institute for Technological Research (Vito), Boeretang 200, B-2400 Mol, Belgium.
| | | | | | | | | |
Collapse
|
34
|
Mouz S, Merlin C, Springael D, Toussaint A. A GntR-like negative regulator of the biphenyl degradation genes of the transposon Tn4371. Mol Gen Genet 1999; 262:790-9. [PMID: 10628862 DOI: 10.1007/s004380051142] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
Tn4371, a 55-kb catabolic transposon originally isolated from Ralstonia eutropha A5, carries genes for the degradation of biphenyl/4-chlorobiphenyl, which are clustered on a 13-kb DNA segment located in the middle of the element. DNA sequencing revealed that two potential regulatory genes, bphR and bphS, border this region. Transcriptional fusion experiments using bphC as a reporter gene, Northern hybridization and primer extension analysis led to the conclusion that the transposon-encoded genes bphEFGA1A2A3BCD form an operon transcribed from a sigma70 promoter, pE. Transcription from pE was not influenced by deletion of the bphR gene of Tn4371, which should encode a LysR-like regulator. The bphS gene product negatively regulated pE, and displayed significant similarity to GntR-like regulators. This is the first reported example of a GntR-like regulator involved in the control of an aromatic degradation pathway.
Collapse
Affiliation(s)
- S Mouz
- Laboratoire de Microbiologie, Université J. Fourier, Grenoble, France
| | | | | | | |
Collapse
|
35
|
Lamrani S, Ranquet C, Gama MJ, Nakai H, Shapiro JA, Toussaint A, Maenhaut-Michel G. Starvation-induced Mucts62-mediated coding sequence fusion: a role for ClpXP, Lon, RpoS and Crp. Mol Microbiol 1999; 32:327-43. [PMID: 10231489 DOI: 10.1046/j.1365-2958.1999.01352.x] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The formation of araB-lacZ coding sequence fusions in Escherichia coli is a particular type of chromosomal rearrangement induced by Mucts62, a thermoinducible mutant of mutator phage Mu. Fusion formation is controlled by the host physiology. It only occurs after aerobic carbon starvation and requires the phage-encoded transposase pA, suggesting that these growth conditions trigger induction of the Mucts62 prophage. Here, we show that thermal induction of the prophage accelerated araB-lacZ fusion formation, confirming that derepression is a rate-limiting step in the fusion process. Nonetheless, starvation conditions remained essential to complete fusions, suggesting additional levels of physiological regulation. Using a transcriptional fusion indicator system in which the Mu early lytic promoter is fused to the reporter E. coli lacZ gene, we confirmed that the Mucts62 prophage was derepressed in stationary phase (S derepression) at low temperature. S derepression did not apply to prophages that expressed the Mu wild-type repressor. It depended upon the host ClpXP and Lon ATP-dependent proteases and the RpoS stationary phase-specific sigma factor, but not upon Crp. None of these four functions was required for thermal induction. Crp was required for fusion formation, but only when the Mucts62 prophage encoded the transposition/replication activating protein pB. Finally, we found that thermally induced cultures did not return to the repressed state when shifted back to low temperature and, hence, remained activated for accelerated fusion formation upon starvation. The maintenance of the derepressed state required the ClpXP and Lon host proteases and the prophage Ner-regulatory protein. These observations illustrate how the cts62 mutation in Mu repressor provides the prophage with a new way to respond to growth phase-specific regulatory signals and endows the host cell with a new potential for adaptation through the controlled use of the phage transposition machinery.
Collapse
Affiliation(s)
- S Lamrani
- Laboratoire de Génétique des Procaryotes, Département de Biologie Moléculaire, Université Libre de Bruxelles, 67 rue des Chevaux, B1640 Rhode St Genèse, Belgium
| | | | | | | | | | | | | |
Collapse
|
36
|
Merlin C, Springael D, Toussaint A. Tn4371: A modular structure encoding a phage-like integrase, a Pseudomonas-like catabolic pathway, and RP4/Ti-like transfer functions. Plasmid 1999; 41:40-54. [PMID: 9887305 DOI: 10.1006/plas.1998.1375] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Tn4371 is a 55-kb catabolic transposon originally isolated from Ralstonia eutropha A5 that encodes enzymes catalyzing the complete degradation of biphenyl. Unlike previously described transposons encoding similar genes for aromatic compound degradation. Tn4371 carries a phage-like degradation, Tn4371 integrase gene and RP4/Ti-like transfer genes. Tn4371 transposition involves an excision/integration process and, consistent with this site-specific recombination mechanism, the ends of the element are transiently covalently bound. Transposition is targeted to a limited number of sites on the CH34 chromosome and pMOL30 plasmid as well as on RP4. One of these sites consists of a 5'-TTTTTCAT-3' sequence which is also present between the covalently joined ends of the transposon. Conjugative transfer of Tn4371 could not yet be demonstrated although the functionality of its transfer machinery could be established through the identification of a second transposable element, Tn-bph, which contains the right half of Tn4371, including the bph catabolic gene cluster and the identified transfer genes. Tn-bph transfers by conjugation and integrates in a new host genome independently of the larger element. Tn4371 thus appears as composite transposon combining an enteric phage-like integration system, RP4/Ti-like conjugation genes, and Pseudomonas-like catabolic genes.
Collapse
Affiliation(s)
- C Merlin
- Laboratoire de Microbiologie, Université Joseph Fourier, Grenoble Cedex 9, F38041,
| | | | | |
Collapse
|
37
|
Merlin C, Toussaint A. Les éléments transposables bactériens. Med Sci (Paris) 1999. [DOI: 10.4267/10608/1491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
38
|
Grimaud R, Toussaint A. Assembly of both the head and tail of bacteriophage Mu is blocked in Escherichia coli groEL and groES mutants. J Bacteriol 1998; 180:1148-53. [PMID: 9495752 PMCID: PMC107001 DOI: 10.1128/jb.180.5.1148-1153.1998] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/1996] [Accepted: 12/18/1997] [Indexed: 02/06/2023] Open
Abstract
Like several other Escherichia coli bacteriophages, transposable phage Mu does not develop normally in groE hosts (M. Pato, M. Banerjee, L. Desmet, and A. Toussaint, J. Bacteriol. 169:5504-5509, 1987). We show here that lysates obtained upon induction of groE Mu lysogens contain free inactive tails and empty heads. GroEL and GroES are thus essential for the correct assembly of both Mu heads and Mu tails. Evidence is presented that groE mutations inhibit processing of the phage head protein gpH as well as the formation of a 25S complex suspected to be an early Mu head assembly intermediate.
Collapse
Affiliation(s)
- R Grimaud
- Unité Transposition Bactérienne, Université Libre de Bruxelles, Rhode St Genèse, Belgium.
| | | |
Collapse
|
39
|
Abstract
In bacteria lysogenic for bacteriophage Mu, the phage repressor binds to a tripartite operator region, O1,O2,O3, to repress the lytic promoter pE, located in O2, and negatively autoregulate its own synthesis at the pCM promoter located in O3. We isolated and characterized operator mutations which lead to derepression of pE. Their location in the first and third repressor-consensus-binding sequences in O2 confirms the importance of these sites for repressor/operator interactions.
Collapse
Affiliation(s)
- L Desmet
- Laboratoire de Génétique des Procaryotes, Université Libre de Bruxelles, Rhode St Genèse Belgium
| | | | | | | | | | | |
Collapse
|
40
|
Merlin C, Springael D, Mergeay M, Toussaint A. Organisation of the bph gene cluster of transposon Tn4371, encoding enzymes for the degradation of biphenyl and 4-chlorobiphenyl compounds. Mol Gen Genet 1997; 253:499-506. [PMID: 9037111 DOI: 10.1007/s004380050349] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Tn4371 is a 55 kb transposon which encodes enzymes for the degradation of biphenyl and 4-chlorobiphenyl compounds into benzoate and 4-chlorobenzoate derivatives. We constructed a cosmid library of Tn4371 DNA. The bph genes involved in biphenyl/4-chlorobiphenyl degradation were found to be clustered in the middle of the transposon. Sequencing revealed an organisation of the bph genes similar to that previously found in Pseudomonas sp. KKS102, i.e. the bphEGF genes are located upstream of bphA1A2A3 and bphA4 is separated from bphA1A2A3 by bphBCD. Consensus sequences for sigma54-associated RNA polymerase were found upstream of bphA1 and bphEGF. Plasmid RP4::Tn4371 was transferred into a mutant of Alcaligenes eutrophus H16 lacking sigma54. In contrast to wild-type H16 exconjugants, the sigma54 mutant exconjugants could not grow on biphenyl, indicating the dependence of Tn4371 bph gene expression on sigma54. The Tn4371-encoded bph pathway was activated when biphenyl and various biphenyl-like compounds were present in the growth medium. Preliminary observations indicate the presence of a region outside the catabolic genes downstream of bphA4 which is involved in mediating at least the basal expression of BphC.
Collapse
Affiliation(s)
- C Merlin
- Laboratoire de Microbiologie, Université Joseph Fourier, Grenoble, France
| | | | | | | |
Collapse
|
41
|
Sauret-Ignazi G, Gagnon J, Béguin C, Barrelle M, Markowicz Y, Pelmont J, Toussaint A. Characterisation of a chromosomally encoded catechol 1,2-dioxygenase (E.C. 1.13.11.1) from Alcaligenes eutrophus CH34. Arch Microbiol 1996; 166:42-50. [PMID: 8661943 DOI: 10.1007/s002030050353] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Alcaligenes eutrophus CH34 used benzoate as a sole source of carbon and energy, degrading it through the 3-oxoadipate pathway. All the enzymes required for this degradation were shown to be encoded by chromosomal genes. Catechol 1,2-dioxygenase activity was induced by benzoate, catechol, 4-chlorocatechol, and muconate. The enzyme is most likely a homodimer, with an apparent molecular weight of 76,000 +/- 500. According to several criteria, its properties are intermediate between those of catechol 1,2-dioxygenases (CatA) and chlorocatechol 1,2-dioxygenases (ClcA). The determined Km for catechol is the lowest among known catechol and chlorocatechol dioxygenases. Similar Km values were found for para-substituted catechols, although the catalytic constants were much lower. The catechol 1,2-dioxygenase from strain CH34 is unique in its property to transform tetrachlorocatechol; however, excess substrate led to a marked reversible inhibition. Some meta- and multi-substituted catechols behaved similarly. The determined Km (or Ki) values for para- or meta-substituted catechols suggest that the presence of an electron-withdrawing substituent at one of these positions results in a higher affinity of the enzyme for the ligand. Results of studies of recognition by the enzyme of various nonmetabolised aromatic compounds are also discussed.
Collapse
Affiliation(s)
- G Sauret-Ignazi
- Laboratoire de Génétique Microbienne (DRED JE 117), Université Joseph Fourier, BP 53, F-38041 Grenoble cédex 9, France
| | | | | | | | | | | | | |
Collapse
|
42
|
Vogel JL, Geuskens V, Desmet L, Higgins NP, Toussaint A. C-terminal deletions can suppress temperature-sensitive mutations and change dominance in the phage Mu repressor. Genetics 1996; 142:661-72. [PMID: 8849877 PMCID: PMC1207008 DOI: 10.1093/genetics/142.3.661] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
Mutations in an N-terminal 70-amino acid domain of bacteriophage Mu's repressor cause temperature-sensitive DNA-binding activity. Surprisingly, amber mutations can conditionally correct the heat-sensitive defect in three mutant forms of the repressor gene, cts25 (D43-G), cts62 (R47-Q) and cts71 (M28-I), and in the appropriate bacterial host produce a heat-stable Sts phenotype (for survival of temperature shifts). Sts repressor mutants are heat sensitive when in supE or supF hosts and heat resistant when in Sup degrees hosts. Mutants with an Sts phenotype have amber mutations at one of three codons, Q179, Q187, or Q190. The Sts phenotype relates to the repressor size: in Sup degrees hosts sts repressors are shorter by seven, 10, or 18 amino acids compared to repressors in supE or supF hosts. The truncated form of the sts62-1 repressor, which lacks 18 residues (Q179-V196), binds Mu operator DNA more stably at 42 degrees in vitro compared to its full-length counterpart (cts62 repressor). In addition to influencing temperature sensitivity, the C-terminus appears to control the susceptibility to in vivo Clp proteolysis by influencing the multimeric structure of repressor.
Collapse
Affiliation(s)
- J L Vogel
- Department of Biochemistry, University of Alabama, Birmingham 35294, USA
| | | | | | | | | |
Collapse
|
43
|
Laachouch JE, Desmet L, Geuskens V, Grimaud R, Toussaint A. Bacteriophage Mu repressor as a target for the Escherichia coli ATP-dependent Clp Protease. EMBO J 1996. [DOI: 10.1002/j.1460-2075.1996.tb00374.x] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
44
|
Laachouch JE, Desmet L, Geuskens V, Grimaud R, Toussaint A. Bacteriophage Mu repressor as a target for the Escherichia coli ATP-dependent Clp Protease. EMBO J 1996; 15:437-44. [PMID: 8617219 PMCID: PMC449959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Bacteriophage Mu repressor, which is stable in its wildtype form, can mutate to become sensitive to its Escherichia coli host ATP-dependent ClpXP protease. We further investigated the determinants of the mutant repressor's sensitivity to Clp. We show the crucial importance of a C-terminal, seven amino acid long sequence in which a single change is sufficient to decrease the rate of degradation of the protein. The sequence was fused at the C-terminal end of the CcdB and CcdA proteins encoded by plasmid F. CcdB, which is naturally stable, was unaffected, while CcdA, which is normally degraded by the Lon protease, became a substrate for ClpXP while remaining a substrate for Lon. In agreement with the current hypothesis on the mechanism of recognition of their substrates by energy- dependent proteases, these results support the existence, on the substrate polypeptides, of separate motifs responsible for recognition and cleavage by the protease.
Collapse
Affiliation(s)
- J E Laachouch
- Laboratorie de Génétique des Procaryotes, Université Libre de Bruxelles, Genese, Belgium
| | | | | | | | | |
Collapse
|
45
|
Abstract
Bacteriophage Mu does not grow on temperature-sensitive E. coli dnaK mutants at elevated temperatures because of a defect in late transcription. As the Mu-encoded C protein is required for activation of transcription from the phage late promoters, we attempted to determine if DnaK and its accessory proteins DnaJ and GrpE are required for synthesis of C protein or at a later step. We found that the chaperones act in Mu late transcription beyond C-protein synthesis, and that C-protein stability is decreased in the mutant hosts. This suggests that the DnaK chaperone machine may be required for the proper folding and/or multimerization of C protein.
Collapse
Affiliation(s)
- O Sand
- Département de Biologie Moléculaire, Université Libre de Bruxelles, Belgium
| | | | | | | |
Collapse
|
46
|
Abstract
We have investigated the possibility of growing mutator phages from Pseudomonas aeruginosa on various isolates of Alcaligenes eutrophus. Although none out of 10 A. eutrophus strains were susceptible to infection with any of the phages tested, phage D3112 could be readily transferred in our model strain CH34 by means of an RP4::D3112 plasmid. CH34/RP4::D3112 lysogens were stable and produced phages. However, neither mitomycin C nor UV treatment increased the phage yield.
Collapse
Affiliation(s)
- V Krylov
- Institute for Genetics of Microorganisms, Moscow
| | | | | |
Collapse
|
47
|
Mhammedi-Alaoui A, Pato M, Gama MJ, Toussaint A. A new component of bacteriophage Mu replicative transposition machinery: the Escherichia coli ClpX protein. Mol Microbiol 1994; 11:1109-16. [PMID: 8022280 DOI: 10.1111/j.1365-2958.1994.tb00387.x] [Citation(s) in RCA: 108] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
We have shown previously that some particular mutations in bacteriophage Mu repressor, the frameshift vir mutations, made the protein very sensitive to the Escherichia coli ATP-dependent Clp protease. This enzyme is formed by the association between a protease subunit (ClpP) and an ATPase subunit. ClpA, the best characterized of these ATPases, is not required for the degradation of the mutant Mu repressors. Recently, a new potential ClpP associated ATPase, ClpX, has been described. We show here that this new subunit is required for Mu vir repressor degradation. Moreover, ClpX (but not ClpP) was found to be required for normal Mu replication. Thus ClpX has activities that do not require its association with ClpP. In the pathway of Mu replicative transposition, the block resides beyond the strand transfer reaction, i.e. after the transposition reaction per se is completed, suggesting that ClpX is required for the transition to the formation of the active replication complex at one Mu end. This is a new clear-cut case of the versatile activity of polypeptides that form multi-component ATP-dependent proteases.
Collapse
Affiliation(s)
- A Mhammedi-Alaoui
- Unité Transposition Bactérienne, Université Libre de Bruxelles, Rhode St Genèse, Belgium
| | | | | | | |
Collapse
|
48
|
Abstract
Bacteriophage Mu is a transposon and a temperate phage which has become a paradigm for the study of the molecular mechanism of transposition. As a prophage, Mu has also been used to study some aspects of the influence of the host cell growth phase on the regulation of transposition. Through the years several host proteins have been identified which play a key role in the replication of the Mu genome by successive rounds of replicative transposition as well as in the maintenance of the repressed prophage state. In this review we have attempted to summarize all these findings with the purpose of emphasizing the benefit the virus and the host cell can gain from those phage-host interactions.
Collapse
Affiliation(s)
- A Toussaint
- Laboratoire de Génétique, Université Libre de Bruxelles, Rhode St Genèse, Belgium
| | | | | | | | | |
Collapse
|
49
|
Abstract
Two Erwinia chrysanthemi homologues of the himA and himD genes of Escherichia coli which encode the integration host factor (IHF) were cloned, sequenced and compared to their homolog in other enterobacteria (EMBL accession nos X74749 and X74750). Both genes were inactivated by the insertion of an antibiotic resistance cassette, allowing for the isolation of IHF- mutants of E chrysanthemi.
Collapse
Affiliation(s)
- A Douillié
- Laboratoire de Génétique, Unité Transposition bactérienne, Université Libre de Bruxelles, Rhode-Saint-Genèse, Belgium
| | | | | |
Collapse
|
50
|
Abstract
Nineteen strains of Alcaligenes eutrophus were tested for the presence of prophages. One strain that lysed upon mitomycin C treatment produced a phage which could not form plaques on any of the strains available. DNA extracted from partially purified phage lysates was digested with various restriction enzymes which showed that the 42 kb long viral double-stranded DNA circularizes by means of cohesive ends. To our knowledge, this is the first description of a phage for the genus Alcaligenes.
Collapse
Affiliation(s)
- M Faelen
- Laboratoire de Génétique, Université Libre de Bruxelles, Rhode St Genèse, Belgium
| | | | | | | | | |
Collapse
|